T44.7X2D Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, subsequent encounter

Name of the Condition

• Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, subsequent encounter
• This code represents intentional self-harm poisoning from beta-adrenoreceptor antagonists (beta-blockers) during a subsequent encounter for the condition.

Summary

Intentional self-harm poisoning by beta-adrenoreceptor antagonists occurs when a patient deliberately ingests or is exposed to excessive amounts of beta-blockers with the intent to cause harm. Beta-blockers are medications used to manage cardiovascular conditions like hypertension, angina, and arrhythmias. The subsequent encounter indicates care provided after the initial treatment for the poisoning.

Causes

Intentional self-harm poisoning may result from deliberate overdose, misuse of prescribed medications, or intentional exposure to beta-blockers. It can occur due to psychological distress, suicidal ideation, or attempts to self-harm.

Risk Factors

• History of mental health conditions (e.g., depression, anxiety, or suicidal behavior).
• Access to beta-blocker medications.
• Previous episodes of self-harm or overdose.
• Social or environmental stressors contributing to intentional harm.

Symptoms

• Bradycardia (slow heart rate) or hypotension (low blood pressure).
• Dizziness, fatigue, or syncope (fainting).
• Cold extremities or cyanosis.
• Respiratory distress or cardiac arrhythmias.
• Altered mental status or confusion.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, patient history (including intent), and laboratory tests to confirm beta-blocker exposure. Healthcare providers assess the severity of poisoning, vital signs, and organ function. Toxicology screening may be used to identify the specific agent and quantify levels.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and preventing further harm. Interventions may include supportive care (e.g., fluids, oxygen), medications to reverse effects (e.g., glucagon), or activated charcoal if ingestion was recent. Psychiatric evaluation and counseling are critical for addressing underlying intent.

Prognosis and Follow-Up

Prognosis depends on the dose ingested, timeliness of treatment, and patient response. Subsequent encounters require monitoring for complications and ongoing psychiatric support. Follow-up care ensures recovery and addresses mental health needs to reduce recurrence risk.

Complications

• Severe bradycardia or cardiac arrest.
• Hypotension leading to shock.
• Respiratory failure or aspiration.
• Long-term organ damage from prolonged exposure.
• Recurrent self-harm or suicidal behavior.

Lifestyle & Prevention

• Secure storage of medications to prevent access.
• Regular mental health check-ins for at-risk individuals.
• Education on medication safety and proper disposal.
• Support systems for managing stress or emotional distress.

When to Seek Professional Help

Seek immediate medical attention if symptoms of poisoning (e.g., dizziness, fainting, or altered consciousness) occur after beta-blocker exposure. Prompt care is critical to prevent severe complications. Psychiatric evaluation is recommended for intentional self-harm to address underlying issues.

Tips for Medical Coders

Document the intent (intentional self-harm) and encounter type (subsequent) clearly. Include details on the patient’s history, treatment provided, and any psychiatric involvement. Ensure the code aligns with clinical documentation to reflect the nature of the poisoning and care setting.